CHRNA10
Neuronal acetylcholine receptor subunit alpha-10
Also known as: ACH10_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9GZZ6
- Gene
- CHRNA10
- Ensembl
- ENSG00000129749
- Chromosome
- 11
- Canonical length
- 450 aa
- Protein class
- FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
Predicted to enable excitatory extracellular ligand-gated monoatomic ion channel activity; serotonin-gated monoatomic cation channel activity; and transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential. Acts upstream of or within positive regulation of cytosolic calcium ion concentration. Predicted to be located in membrane. Predicted to be part of transmembrane transporter complex. Predicted to be active in cholinergic synapse; neuron projection; and postsynaptic specialization membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
450 residues, UniProt reviewed canonical sequence.
>Q9GZZ6|CHRNA10
1 MGLRSHHLSL GLLLLFLLPA ECLGAEGRLA LKLFRDLFAN YTSALRPVAD TDQTLNVTLE
61 VTLSQIIDMD ERNQVLTLYL WIRQEWTDAY LRWDPNAYGG LDAIRIPSSL VWRPDIVLYN
121 KADAQPPGSA STNVVLRHDG AVRWDAPAIT RSSCRVDVAA FPFDAQHCGL TFGSWTHGGH
181 QLDVRPRGAA ASLADFVENV EWRVLGMPAR RRVLTYGCCS EPYPDVTFTL LLRRRAAAYV
241 CNLLLPCVLI SLLAPLAFHL PADSGEKVSL GVTVLLALTV FQLLLAESMP PAESVPLIGK
301 YYMATMTMVT FSTALTILIM NLHYCGPSVR PVPAWARALL LGHLARGLCV RERGEPCGQS
361 RPPELSPSPQ SPEGGAGPPA GPCHEPRCLC RQEALLHHVA TIANTFRSHR AAQRCHEDWK
421 RLARVMDRFF LAIFFSMALV MSLLVLVQALLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CHRNA10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 45 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 45 nTPM
- cerebellum: 2.1 nTPM
- spleen: 1.8 nTPM
- liver: 1.6 nTPM
- choroid plexus: 1.5 nTPM
- kidney: 1.4 nTPM
Single-cell type
- neutrophils: 9.5 nCPM
- endometrial glandular cells: 5.3 nCPM
- thymic myoid cells: 4.1 nCPM
- paneth cells: 3.9 nCPM
- endometrial luminal cells: 3.8 nCPM
- endometrial secretory cells: 3.6 nCPM
Immune cell
- neutrophil: 0.3 nTPM
- gdT-cell: 0.1 nTPM
- memory CD4 T-cell: 0.1 nTPM
- non-classical monocyte: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- cerebral cortex: 2.3 nTPM
- cerebellum: 2 nTPM
- amygdala: 1.5 nTPM
- choroid plexus: 1.5 nTPM
- pons: 1.4 nTPM
- basal ganglia: 1.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.43
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.14
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chemical synaptic transmission
- detection of mechanical stimulus involved in sensory perception of sound
- inner ear morphogenesis
- membrane depolarization
- monoatomic ion transmembrane transport
- negative regulation of ERK1 and ERK2 cascade
- positive regulation of cytosolic calcium ion concentration
- regulation of cell population proliferation
- regulation of membrane potential
- response to auditory stimulus
- synaptic transmission, cholinergic
Molecular functions
- acetylcholine-gated monoatomic cation-selective channel activity
- calcium channel activity
- excitatory extracellular ligand-gated monoatomic ion channel activity
- serotonin-gated monoatomic cation channel activity
- signaling receptor binding
- transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Nicotinic acetylcholine receptor
- Neurotransmitter-gated ion-channel transmembrane domain
- Neurotransmitter-gated ion-channel
- Neurotransmitter-gated ion-channel ligand-binding domain
- Neurotransmitter-gated ion-channel, conserved site
- Neurotransmitter-gated ion-channel transmembrane domain superfamily
- Neurotransmitter-gated ion-channel ligand-binding domain superfamily
- Neuronal acetylcholine receptor
- Neurotransmitter-gated ion-channel ligand binding domain
- Neurotransmitter-gated ion-channel transmembrane region
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CHRNA10 as an antibody target. Whether an autoantibody or antibody against CHRNA10 could matter depends on whether native CHRNA10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CHRNA10 is annotated at the cell surface, where native CHRNA10 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CHRNA10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...